{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:06:25Z","timestamp":1790802385529,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.radonc.2025.111119","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:02:30Z","timestamp":1757170950000},"page":"111119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prediction of metastasis-free survival in patients with localized prostate adenocarcinoma using primary tumor and lymph node radiomics from pre-treatment PSMA-PET\/CT scans"],"prefix":"10.1016","volume":"212","author":[{"given":"Apurva","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Silva","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Bo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6908-3412","authenticated-orcid":false,"given":"Ozan Cem","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-3391","authenticated-orcid":false,"given":"Aysenur","family":"Elmali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birhan","family":"Demirhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuoc","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-9021","authenticated-orcid":false,"given":"Cem","family":"Onal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.radonc.2025.111119_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J Clin"},{"issue":"2","key":"10.1016\/j.radonc.2025.111119_b0010","first-page":"307","article-title":"Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer: Interdisciplinary International Journal of the","volume":"112","author":"Agarwal","year":"2008","journal-title":"Am Cancer Soc"},{"issue":"17","key":"10.1016\/j.radonc.2025.111119_b0015","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"J Am Med Assoc"},{"issue":"24","key":"10.1016\/j.radonc.2025.111119_b0020","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.radonc.2025.111119_b0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2014.12.017","article-title":"Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients","volume":"91","author":"Wortel","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.radonc.2025.111119_b0030","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2013.53.8652","article-title":"Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity","volume":"32","author":"Yu","year":"2014","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.radonc.2025.111119_b0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.brachy.2014.03.002","article-title":"High-dose-rate brachytherapy as monotherapy for prostate cancer","volume":"13","author":"Demanes","year":"2014","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.radonc.2025.111119_b0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.6004\/jnccn.2014.0072","article-title":"Prostate cancer, version 2.2014","volume":"12","author":"Mohler","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.radonc.2025.111119_b0045","article-title":"Screening for prostate cancer","volume":"1","author":"Ilic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.radonc.2025.111119_b0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bju.12854","article-title":"Guideline of guidelines: prostate cancer screening","volume":"114","author":"Loeb","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2025.111119_b0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/bju.13411","article-title":"Men presenting with prostate\u2010specific antigen (PSA) values of over 100 ng\/mL","volume":"117","author":"Ang","year":"2016","journal-title":"BJU Int"},{"issue":"10231","key":"10.1016\/j.radonc.2025.111119_b0060","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.radonc.2025.111119_b0065","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1097\/RLU.0000000000002691","article-title":"Integration of 68Ga-PSMA-PET\/CT in radiotherapy planning for prostate cancer patients","volume":"44","author":"Onal","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.radonc.2025.111119_b0070","first-page":"C975","article-title":"Is prostate-specific membrane antigen a multifunctional protein?","volume":"288","author":"Rajasekaran","year":"2005","journal-title":"Am J Phys Cell Phys"},{"issue":"4","key":"10.1016\/j.radonc.2025.111119_b0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.radonc.2025.111119_b0080","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial","volume":"20","author":"Calais","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111119_b0085","first-page":"10","article-title":"Evaluation of treatment outcomes of prostate cancer patients with lymph node metastasis treated with definitive radiotherapy: comparative analysis of PSMA PET\/CT and conventional imaging","volume":"11","author":"Onal","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.radonc.2025.111119_b0090","doi-asserted-by":"crossref","unstructured":"Ling X, Alexander GS, Molitoris J, Choi J, Schumaker L, Mehra R, Gaykalova DA, Ren L. Identification of CT-based non-invasive Radiographic Biomarkers for Overall Survival Stratification in Oral Cavity Squamous Cell Carcinoma. Research Square. 2023.","DOI":"10.21203\/rs.3.rs-3263887\/v1"},{"key":"10.1016\/j.radonc.2025.111119_b0095","article-title":"Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer","author":"Wang","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111119_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1380599","article-title":"Radiomic biomarkers of locoregional recurrence: prognostic insights from oral cavity squamous cell carcinoma preoperative CT scans","volume":"14","author":"Ling","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111119_b0105","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41598-025-85498-x","article-title":"Identification of CT based radiomic biomarkers for progression free survival in head and neck squamous cell carcinoma","volume":"15","author":"Ling","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.radonc.2025.111119_b0110","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jamaoncol.2016.2631","article-title":"The potential of radiomic-based phenotyping in precision medicine: a review","volume":"2","author":"Aerts","year":"2016","journal-title":"JAMA Oncol"},{"issue":"24","key":"10.1016\/j.radonc.2025.111119_b0115","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1002\/cncr.31630","article-title":"Quantitative imaging of cancer in the postgenomic era: Radio (geno) mics, deep learning, and habitats","volume":"124","author":"Napel","year":"2018","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.radonc.2025.111119_b0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lungcan.2014.08.016","article-title":"Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01)","volume":"86","author":"Chouaid","year":"2014","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.radonc.2025.111119_b0125","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jtho.2018.05.030","article-title":"Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC","volume":"13","author":"Rolfo","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.111119_b0130","doi-asserted-by":"crossref","unstructured":"Singh A, Horng H, Roshkovan L, Katz SI, Kontos D, Thompson JC. Radiomics analysis to diagnose tumor invasiveness of pulmonary sub-solid nodules from longitudinal pre-surgical CT scans. InMedical Imaging 2023: Computer-Aided Diagnosis 2023 (Vol. 12465, pp. 577-581). SPIE.","DOI":"10.1117\/12.2653949"},{"issue":"1","key":"10.1016\/j.radonc.2025.111119_b0135","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1038\/s41598-022-14160-7","article-title":"Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy","volume":"12","author":"Singh","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2025.111119_b0140","unstructured":"Sutera P, Deek M, Guler OC, Hurmuz P, Reyhan M, Rowe SP, Hrinivich W, Ren L, Kiess AP, Song DY, Oymak E. Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer."},{"issue":"7","key":"10.1016\/j.radonc.2025.111119_b0145","article-title":"Prostate-specific membrane antigen PET response associates with metastasis-free survival after stereotactic ablative radiation in oligometastatic prostate cancer","volume":"9","author":"Sutera","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"199","key":"10.1016\/j.radonc.2025.111119_b0150","article-title":"Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics","volume":"1","author":"Cao","year":"2024","journal-title":"Radiother Oncol"},{"issue":"27","key":"10.1016\/j.radonc.2025.111119_b0155","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1200\/JCO.2017.73.9987","article-title":"Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer","volume":"35","author":"Xie","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2025.111119_b0160","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111119_b0165","doi-asserted-by":"crossref","unstructured":"Pieper S, Halle M, Kikinis R. 3D Slicer. In2004 2nd IEEE international symposium on biomedical imaging: nano to macro (IEEE Cat No. 04EX821) 2004 (pp. 632-635). IEEE.","DOI":"10.1109\/ISBI.2004.1398617"},{"issue":"21","key":"10.1016\/j.radonc.2025.111119_b0170","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"Van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2025.111119_b0175","first-page":"1055","article-title":"Z-scores","volume":"3","author":"Abdi","year":"2007","journal-title":"Encyclopedia of measurement and statistics"},{"issue":"4","key":"10.1016\/j.radonc.2025.111119_b0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/wics.101","article-title":"Principal component analysis","volume":"2","author":"Abdi","year":"2010","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"issue":"16","key":"10.1016\/j.radonc.2025.111119_b0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"1","author":"Chawla","year":"2002","journal-title":"J Artif Intell Res"},{"issue":"sup133","key":"10.1016\/j.radonc.2025.111119_b0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/00365528709091021","article-title":"The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analyses","volume":"22","author":"Maruyama","year":"1987","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.radonc.2025.111119_b0195","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.1840070628","article-title":"Multivariate survival analysis using Cox\u2019s regression model","volume":"7","author":"Christensen","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.radonc.2025.111119_b0200","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.453","article-title":"scikit-image: image processing in Python","volume":"2","author":"Van der Walt","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.radonc.2025.111119_b0205","unstructured":"Statistics and machine Learning Toolbox version: 9.4 (R2022b), Natick, Massachusetts: The MathWorks Inc.; 2022."},{"issue":"10","key":"10.1016\/j.radonc.2025.111119_b0210","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C\u2010statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2025.111119_b0215","unstructured":"Team RD. R: A language and environment for statistical computing. (No Title). 2010."},{"issue":"2","key":"10.1016\/j.radonc.2025.111119_b0220","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/diagnostics11020186","article-title":"Estimating the potential of radiomics features and radiomics signature from pretherapeutic PSMA-PET-CT scans and clinical data for prediction of overall survival when treated with 177Lu-PSMA","volume":"11","author":"Moazemi","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.radonc.2025.111119_b0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-022-00936-5","article-title":"Development and validation of 68Ga-PSMA-11 PET\/CT-based radiomics model to detect primary prostate cancer","volume":"12","author":"Zang","year":"2022","journal-title":"EJNMMI Res"},{"issue":"3","key":"10.1016\/j.radonc.2025.111119_b0230","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2018180910","article-title":"Perinodular and intranodular radiomic features on lung CT images distinguish adenocarcinomas from granulomas","volume":"290","author":"Beig","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2025.111119_b0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2021.09.008","article-title":"Development and prospective validation of a spatial dose pattern based model predicting acute pulmonary toxicity in patients treated with volumetric arc-therapy for locally advanced lung cancer","author":"Bourbonne","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111119_b0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13014-024-02409-6","article-title":"Development and validation of survival prognostic models for head and neck cancer patients using machine learning and dosiomics and CT radiomics features: a multicentric study","volume":"19","author":"Mansouri","year":"2024","journal-title":"Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025046237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025046237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:19:08Z","timestamp":1780114748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025046237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":48,"alternative-id":["S0167814025046237"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111119","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of metastasis-free survival in patients with localized prostate adenocarcinoma using primary tumor and lymph node radiomics from pre-treatment PSMA-PET\/CT scans","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111119"}}